Navigation Links
Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, will be relocating its West Coast office from San Francisco to San Diego.  Thomas, McNerney partner Pratik Shah, Ph.D. announced the move at BIOCOM's first global partnering conference being held in San Diego.

"Southern California is home to many top-tier scientific and medical centers; it's long been a fertile breeding ground for successful medical technology companies, and it's populated by some of the smartest, most capable people in the country," Dr. Shah said.  "It has all the ingredients that make it an ideal home for Thomas, McNerney's West Coast office." Thomas, McNerney & Partners has ten investments on the West Coast, six of which are in Southern California.

In addition, well known San Diego biopharmaceutical executive Larry Fritz, Ph.D. has joined Thomas, McNerney as an Entrepreneur in Residence and will be based out of the firm's new West Coast office.  Dr. Fritz has founded or co-founded a string of successful biotechnology companies including Athena Neurosciences, Idun, Conforma, Cabrellis and Covella.  He will assist Thomas, McNerney in selecting investments and building companies.  

"Larry has had a long and distinguished career in founding and managing biotechnology companies," said Dr. Shah.  "Importantly, he has been especially successful in creating value for investors and engineering profitable exits in multiple private companies.  Strategically, operationally and scientifically, he is a good fit for the way we do business at Thomas, McNerney, and he will be a great addition to our team."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development.  In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization.  Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations.  The firm has offices in Connecticut, Minnesota and California. For further information, please visit www.tm-partners.com.


'/>"/>
SOURCE Thomas, McNerney & Partners, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
4. Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem
5. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
8. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. Sutter Health Among the Nations Top Employers According to Readers of CAREERS & the disABLED Magazine
11. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
Breaking Medicine Technology:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):